Pediatr Blood Cancer
Antineoplastic Combined Chemotherapy ProtocolsBridged Bicyclo Compounds, HeterocyclicCytarabine
Dr. Seth Evan Karol, MD
NPI1437311297
- Publications
- 85
- Clinical trials
- 4
- Industry payments
- $13,820
- Medical group
- 1
- State licenses
- 2
- Practice address
- 262 Danny Thomas Place, Memphis, TN 38105
- Practice phone
- Call (901) 495-3300
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Karol's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Seth Evan Karol is a pediatric hematology and oncology physician in Memphis, Tennessee
Dr. Karol practices at St. Jude Children's Research Hospital in Memphis, Tennessee, part of St. Jude Childrens Research Hospital.
Dr. Karol's NPI, 1437311297, was assigned on July 1, 2008. Dr. Karol holds Tennessee license 48545.
NPI and contact details
- NPI
- 1437311297NPI Registry (opens in a new tab)
- NPI enumeration date
- July 1, 2008
- NPI status
- Active
- Practice phone
- (901) 495-3300
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Seth Evan Karol practices at St. Jude Children's Research Hospital in Memphis, Tennessee
Dr. Karol's primary practice is St. Jude Children's Research Hospital, at 262 Danny Thomas Place, Memphis, TN 38105 in Shelby County. The practice phone is (901) 495-3300.
- St. Jude Children's Research Hospital262 Danny Thomas Place, Memphis, TN 38105 · Shelby CountyPhone(901) 495-3300
Source: Dmand AI Affiliation Data
Dr. Seth Evan Karol is affiliated with 1 medical group
Dr. Karol's primary practice is St. Jude Children's Research Hospital in Memphis, Tennessee, part of St. Jude Childrens Research Hospital. The medical group on file is St. Jude Children's Research Hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Seth Evan Karol's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karol practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| St. Jude Children's Research Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Karol practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across St. Jude Childrens Research Hospital and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Seth Evan Karol is one of 141 pediatric hematologys and oncology physicians in Tennessee
Pediatric hematology-oncology is Dr. Karol's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dmand AI has Dr. Karol's licenses on file in 2 states: Tennessee and Ohio.
Specialties and state licenses
- Pediatric hematology and oncology, TennesseePrimary
- Pediatrics, Ohio
Pediatric hematologys and oncology physicians near Dr. Karol
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
141pediatric hematologys and oncology physicians in Tennessee100pediatric hematologys and oncology physicians in Memphis85pediatric hematologys and oncology physicians at St. Jude Children's Research Hospital
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Seth Evan Karol's patients have a median age of 9
Across all payers, Dmand AI patient panel data puts Dr. Karol's median patient age at 9, with 31% women.
Dr. Karol's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 9
Patient panel by sex, all payers
- Women31%
- Men69%
Source: Dmand AI Patient Panel Data
Dr. Seth Evan Karol has 85 publications on record
Dmand AI links 85 papers to Dr. Karol, published from 2014 to 2025. 2019 was the busiest year, with 10. The most frequent topics are Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Combined Chemotherapy Protocols and Osteonecrosis. Dr. Karol has published most often in Pediatr Blood Cancer. Dr. Karol's most frequent co-authors are Ching-Hon Pui, MD, Hiroto Inaba, MD and Cheng Cheng.
Papers85
Years published2014 to 2025
Dr. Karol's papers by year, 2015 to 2025
Topics Dr. Karol writes about most
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Antineoplastic Combined Chemotherapy Protocols
- Osteonecrosis
- Leukemia, Myeloid, Acute
- Asparaginase
- Antineoplastic Agents
- Genome-Wide Association Study
- Dexamethasone
Dr. Karol's most frequent co-authors
Recent publications by Dr. Karol
Pediatr Blood Cancer
Antineoplastic Combined Chemotherapy ProtocolsAsparaginaseBridged Bicyclo Compounds, Heterocyclic
See who Dr. Karol researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Karol works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Seth Evan Karol has worked on 4 clinical trials
Dmand AI links Dr. Karol to 4 clinical trials, 2 of them phase 1/2 studies. 2 are still active or recruiting. Conditions studied include Myelodysplastic Syndromes, Osteonecrosis and Precursor Cell Lymphoblastic Leukemia-Lymphoma. St. Jude Children's Research Hospital sponsors the most, 2.
Clinical trials with Dr. Karol by phase
- 1Phase 1: 1 trial
- 2Phase 1/2: 2 trials
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Karol's trials
- Myelodysplastic Syndromes
- Osteonecrosis
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Leukemia, Lymphoid
- Leukemia, Myeloid, Acute
Investigators on the most trials with Dr. Karol
- Leonard Charles Bailey, MD1 shared trial
- Sandeep Batra, MD1 shared trial
- Melissa Kay Bear, MD1 shared trial
Recent clinical trials with Dr. Karol
RAVEN: A Phase I/II Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax (opens in a new tab)
Active, not recruitingPhase 1/2
Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, LymphoidNavitoclaxVenetoclaxBlinatumomab
A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (opens in a new tab)
TerminatedPhase 1/2
PonatinibChemotherapy Agents
Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma (opens in a new tab)
Active, not recruitingPhase 2
OsteonecrosisNecrosisConventional Antihypertensive TherapyIntensive Antihypertensive Therapy
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteAzacitidineCytarabineFludarabine Phosphate
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Seth Evan Karol received $13,820 in industry payments from 2021 to 2025
CMS Open Payments shows 9 general payments to Dr. Karol from 3 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 97% of the total. Servier Pharmaceuticals LLC paid the most, $7,650.
General payments to Dr. Karol by program year, 2021 to 2025
General payments to Dr. Karol by kind, 2021 to 2025
$13.8Kin total
- Consulting fees$13,35097%
- Food and beverage$4703%
Companies that paid Dr. Karol the most, 2021 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Seth Evan Karol's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Seth Evan Karol
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Seth Evan Karol's NPI number?
Dr. Seth Evan Karol's NPI number is 1437311297. It was assigned on July 1, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Seth Evan Karol?
Dr. Seth Evan Karol is a pediatric hematology and oncology physician in Memphis, Tennessee. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Seth Evan Karol practice?
Dr. Karol practices at 262 Danny Thomas Place, Memphis, TN 38105. Dr. Karol's primary practice is St. Jude Children's Research Hospital in Memphis, Tennessee, part of St. Jude Childrens Research Hospital.
What is Dr. Seth Evan Karol's office phone number?
The practice phone on file for Dr. Karol is (901) 495-3300.
What is Dr. Seth Evan Karol's medical license number?
Dr. Karol holds Tennessee license 48545, one of the licenses on file in 2 states.
Which states has Dr. Seth Evan Karol been licensed in?
Dmand AI has state licenses on file for Dr. Karol in Tennessee and Ohio.
Which hospitals is Dr. Seth Evan Karol affiliated with?
Dr. Karol practices at St. Jude Children's Research Hospital in Memphis, Tennessee.
What medical group is Dr. Seth Evan Karol part of?
Dr. Karol is linked to St. Jude Children's Research Hospital.
Has Dr. Seth Evan Karol received payments from drug or device companies?
CMS Open Payments shows $13,820 in general payments to Dr. Karol from 3 companies from 2021 to 2025. The largest total came from Servier Pharmaceuticals LLC.
How long has Dr. Seth Evan Karol been practicing?
Dr. Karol's NPI was assigned in 2008.
Does Dr. Seth Evan Karol do research?
Dmand AI links 85 publications to Dr. Karol, published from 2014 to 2025. Dr. Karol has worked on 4 clinical trials.
Who does Dr. Seth Evan Karol publish with?
Dr. Karol's most frequent co-authors are Ching-Hon Pui, MD (43 shared papers), Hiroto Inaba, MD (32 shared papers) and Cheng Cheng (30 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card